Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia

Table 1 Principal cohort characteristics (n = 59)

Variables	Mean	Standard deviation	Min	Max
Age, years	70.5424	7.43552	56	91
IPSS	22.5333	6.94676	12	33
PSA, ng/ml	6.489	6.59175	0.21	34.43
BMI	23.7269	2.68572	17.99	29.74
TPV, ml	75.9058	29.08218	24.52	146.89

IPSS, international prostate symptom score; PSA, prostate-specific antigen; TPV, total prostate volume

ISSN: 1471-2490